entertainment -WSS

entertainment

author：leisure time 2025-10-01 02:16:35 - browse：8

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

WSS

Hottest summer in 2,000 years puts focus on extreme heat, health

STAT series 'Denied by AI' wins major journalism prizes

STAT series 'Denied by AI' wins major journalism prizes

Biogen nominates mother of director’s child to replace him on board

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

STAT reporters are Pulitzer Prize finalists for investigative reporting

leisure time

entertainment

Wikipedia

Hollywood unions extend contract negotiations for actors

Xenotransplantation trials will require adjusting expectations, experts say

Medical records are filled with copy

Inside the rise of 'mukbang' eating videos

Supreme Court strikes down use of affirmative action

STAT series 'Denied by AI' wins major journalism prizes

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WuXi Biologics beefs up its lobbying operation

Medicare proposal to cover medical devices draws a mixed reaction

Can medical device makers keep up in the race to treat obesity?

knowledge

The White House hikes tariffs on plastic syringes made in China

Xenotransplantation trials will require adjusting expectations, experts say

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

WuXi Biologics execs register to lobby as Congress comes for the company

Xenotransplantation trials will require adjusting expectations, experts say

Ripples from Flovent's discontinuation is killing children with asthma

Wikipedia

Wikipedia

leisure time

focus